Search

everythinglearnresearchcommunity

for

Search:↓

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Artificial hair implantation is generally safe and can restore hair when other treatments fail, but some patients may experience side effects.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Stem cells are crucial for skin repair and new treatments for chronic wounds.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Antiandrogen therapy helps treat genetic hair loss.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.